| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.20e-05 | 120 | 24 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.87e-05 | 200 | 24 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.07e-04 | 13 | 24 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 6.72e-04 | 32 | 24 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | integrin binding | 1.17e-03 | 175 | 24 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.60e-03 | 430 | 24 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.45e-03 | 73 | 24 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | peptidase activity | 7.19e-03 | 654 | 24 | 4 | GO:0008233 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 1.87e-05 | 1077 | 24 | 8 | GO:0098609 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 5.95e-05 | 372 | 24 | 5 | GO:0060485 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.83e-04 | 591 | 24 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | anchoring junction | 6.65e-04 | 976 | 24 | 6 | GO:0070161 | |
| GeneOntologyCellularComponent | cell surface | 1.31e-03 | 1111 | 24 | 6 | GO:0009986 | |
| Domain | Peptidase_M12B_N | 1.99e-07 | 39 | 25 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.99e-07 | 39 | 25 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.21e-07 | 40 | 25 | 4 | PS00427 | |
| Domain | ADAM_MEPRO | 2.21e-07 | 40 | 25 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.21e-07 | 40 | 25 | 4 | PS50214 | |
| Domain | Reprolysin | 2.21e-07 | 40 | 25 | 4 | PF01421 | |
| Domain | Peptidase_M12B | 2.21e-07 | 40 | 25 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 2.44e-07 | 41 | 25 | 4 | IPR001762 | |
| Domain | Disintegrin_CS | 1.17e-06 | 16 | 25 | 3 | IPR018358 | |
| Domain | ADAM_CR | 1.71e-06 | 18 | 25 | 3 | PF08516 | |
| Domain | KELK | 1.72e-06 | 2 | 25 | 2 | PF15796 | |
| Domain | KELK | 1.72e-06 | 2 | 25 | 2 | IPR031597 | |
| Domain | - | 2.38e-06 | 20 | 25 | 3 | 4.10.70.10 | |
| Domain | DISIN | 2.77e-06 | 21 | 25 | 3 | SM00050 | |
| Domain | Disintegrin | 2.77e-06 | 21 | 25 | 3 | PF00200 | |
| Domain | MetalloPept_cat_dom | 3.87e-06 | 81 | 25 | 4 | IPR024079 | |
| Domain | - | 3.87e-06 | 81 | 25 | 4 | 3.40.390.10 | |
| Domain | ADAM_Cys-rich | 6.07e-06 | 27 | 25 | 3 | IPR006586 | |
| Domain | ACR | 6.07e-06 | 27 | 25 | 3 | SM00608 | |
| Domain | ZINC_PROTEASE | 8.28e-06 | 98 | 25 | 4 | PS00142 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.03e-05 | 4 | 25 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.03e-05 | 4 | 25 | 2 | PD011252 | |
| Domain | DMPK_coil | 1.03e-05 | 4 | 25 | 2 | PF08826 | |
| Domain | EGF_extracell | 6.89e-05 | 60 | 25 | 3 | IPR013111 | |
| Domain | EGF_2 | 6.89e-05 | 60 | 25 | 3 | PF07974 | |
| Domain | CNH | 1.55e-04 | 14 | 25 | 2 | SM00036 | |
| Domain | CNH | 1.79e-04 | 15 | 25 | 2 | PS50219 | |
| Domain | CNH_dom | 1.79e-04 | 15 | 25 | 2 | IPR001180 | |
| Domain | CNH | 1.79e-04 | 15 | 25 | 2 | PF00780 | |
| Domain | PBD | 2.04e-04 | 16 | 25 | 2 | SM00285 | |
| Domain | EGF_3 | 2.51e-04 | 235 | 25 | 4 | PS50026 | |
| Domain | EGF-like_dom | 3.13e-04 | 249 | 25 | 4 | IPR000742 | |
| Domain | CRIB | 3.22e-04 | 20 | 25 | 2 | PS50108 | |
| Domain | EGF_1 | 3.43e-04 | 255 | 25 | 4 | PS00022 | |
| Domain | CRIB_dom | 3.56e-04 | 21 | 25 | 2 | IPR000095 | |
| Domain | EGF-like_CS | 3.74e-04 | 261 | 25 | 4 | IPR013032 | |
| Domain | EGF_2 | 3.96e-04 | 265 | 25 | 4 | PS01186 | |
| Domain | Pkinase_C | 1.11e-03 | 37 | 25 | 2 | IPR017892 | |
| Domain | CYSTEINE_SWITCH | 1.37e-03 | 41 | 25 | 2 | PS00546 | |
| Domain | Pkinase_C | 1.43e-03 | 42 | 25 | 2 | PF00433 | |
| Domain | Pept_M10_metallopeptidase | 1.50e-03 | 43 | 25 | 2 | IPR001818 | |
| Domain | AGC-kinase_C | 2.53e-03 | 56 | 25 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.53e-03 | 56 | 25 | 2 | PS51285 | |
| Domain | S_TK_X | 2.53e-03 | 56 | 25 | 2 | SM00133 | |
| Domain | C1_1 | 2.62e-03 | 57 | 25 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 3.30e-03 | 64 | 25 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.30e-03 | 64 | 25 | 2 | PS50081 | |
| Domain | C1 | 3.40e-03 | 65 | 25 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 3.50e-03 | 66 | 25 | 2 | IPR002219 | |
| Domain | EGF | 3.69e-03 | 235 | 25 | 3 | SM00181 | |
| Pubmed | Cloning and chromosomal localization of human Cdc42-binding protein kinase beta. | 4.96e-07 | 2 | 25 | 2 | 10198171 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23833070 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18263588 | ||
| Pubmed | Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor. | 1.49e-06 | 3 | 25 | 2 | 18922894 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 31227006 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 38289148 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.54e-06 | 569 | 25 | 6 | 30639242 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 21953277 | ||
| Pubmed | A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow. | 2.97e-06 | 4 | 25 | 2 | 18854160 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9418861 | ||
| Pubmed | ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. | 4.95e-06 | 5 | 25 | 2 | 17072319 | |
| Pubmed | The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. | 4.95e-06 | 5 | 25 | 2 | 12135759 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 25107909 | ||
| Pubmed | Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. | 7.43e-06 | 6 | 25 | 2 | 19574220 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 15907280 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 29162624 | ||
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 17344430 | ||
| Pubmed | 1.82e-05 | 467 | 25 | 5 | 30194290 | ||
| Pubmed | Understanding the development of oral epithelial organs through single cell transcriptomic analysis. | 1.97e-05 | 73 | 25 | 3 | 35831953 | |
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 18586681 | ||
| Pubmed | CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. | 5.18e-05 | 15 | 25 | 2 | 26503042 | |
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 26395479 | ||
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 19619540 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 7.54e-05 | 18 | 25 | 2 | 39040056 | |
| Pubmed | 1.14e-04 | 22 | 25 | 2 | 18448648 | ||
| Pubmed | 1.24e-04 | 23 | 25 | 2 | 30814516 | ||
| Pubmed | Deletion of Stk40 impairs definitive erythropoiesis in the mouse fetal liver. | 1.24e-04 | 23 | 25 | 2 | 28358362 | |
| Pubmed | 1.36e-04 | 24 | 25 | 2 | 25825872 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.44e-04 | 377 | 25 | 4 | 38117590 | |
| Pubmed | 1.47e-04 | 25 | 25 | 2 | 12522145 | ||
| Pubmed | 1.51e-04 | 730 | 25 | 5 | 34857952 | ||
| Pubmed | 1.72e-04 | 27 | 25 | 2 | 30516471 | ||
| Pubmed | 1.89e-04 | 405 | 25 | 4 | 38187761 | ||
| Pubmed | Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set. | 1.93e-04 | 157 | 25 | 3 | 12466305 | |
| Pubmed | γ-Linolenic acid in maternal milk drives cardiac metabolic maturation. | 2.13e-04 | 30 | 25 | 2 | 37225978 | |
| Pubmed | 2.84e-04 | 179 | 25 | 3 | 19074885 | ||
| Pubmed | 3.77e-04 | 486 | 25 | 4 | 20936779 | ||
| Pubmed | 4.00e-04 | 41 | 25 | 2 | 21282332 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.04e-04 | 202 | 25 | 3 | 33005030 | |
| Pubmed | 4.20e-04 | 42 | 25 | 2 | 29438518 | ||
| Pubmed | 5.12e-04 | 952 | 25 | 5 | 38569033 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 5.35e-04 | 1489 | 25 | 6 | 28611215 | |
| Pubmed | 5.40e-04 | 963 | 25 | 5 | 28671696 | ||
| Pubmed | 5.48e-04 | 48 | 25 | 2 | 35247391 | ||
| Pubmed | A screen for downstream effectors of Neurogenin2 in the embryonic neocortex. | 6.43e-04 | 52 | 25 | 2 | 15328020 | |
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 6.94e-04 | 54 | 25 | 2 | 17151600 | |
| Interaction | PPM1A interactions | 1.52e-06 | 163 | 25 | 5 | int:PPM1A | |
| Interaction | ADAM20 interactions | 8.85e-06 | 4 | 25 | 2 | int:ADAM20 | |
| Interaction | ARL14 interactions | 1.33e-05 | 119 | 25 | 4 | int:ARL14 | |
| Interaction | NRAS interactions | 1.63e-05 | 699 | 25 | 7 | int:NRAS | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 3.31e-03 | 157 | 25 | 2 | chr4q13 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.34e-06 | 27 | 15 | 3 | 47 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.67e-03 | 161 | 15 | 2 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.09e-02 | 193 | 15 | 2 | 594 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.98e-06 | 163 | 25 | 4 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-06 | 175 | 25 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-06 | 175 | 25 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-05 | 149 | 25 | 3 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.72e-05 | 155 | 25 | 3 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.72e-05 | 155 | 25 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 8.72e-05 | 155 | 25 | 3 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.58e-05 | 160 | 25 | 3 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.94e-05 | 162 | 25 | 3 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.94e-05 | 162 | 25 | 3 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 163 | 25 | 3 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 164 | 25 | 3 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.07e-04 | 166 | 25 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.09e-04 | 167 | 25 | 3 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.11e-04 | 168 | 25 | 3 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 169 | 25 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 169 | 25 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.15e-04 | 170 | 25 | 3 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 170 | 25 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 173 | 25 | 3 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 173 | 25 | 3 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 175 | 25 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 175 | 25 | 3 | c31178d7a5a19d7afd336c9ec0e5c493655a6aa4 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 176 | 25 | 3 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.27e-04 | 176 | 25 | 3 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 176 | 25 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 177 | 25 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 25 | 3 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 179 | 25 | 3 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 179 | 25 | 3 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 179 | 25 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-04 | 180 | 25 | 3 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-04 | 180 | 25 | 3 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class (2021.01.30) | 1.36e-04 | 180 | 25 | 3 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.40e-04 | 182 | 25 | 3 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 183 | 25 | 3 | 36b194e366a14ebc4df187bf31c902be3797bfcc | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 1.43e-04 | 183 | 25 | 3 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 1.43e-04 | 183 | 25 | 3 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.43e-04 | 183 | 25 | 3 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 183 | 25 | 3 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 184 | 25 | 3 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.45e-04 | 184 | 25 | 3 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.47e-04 | 185 | 25 | 3 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 185 | 25 | 3 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 185 | 25 | 3 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 186 | 25 | 3 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.50e-04 | 186 | 25 | 3 | 0dce13e15c3bf32610bf2dad31253b52a39cff87 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 186 | 25 | 3 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 25 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 25 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 187 | 25 | 3 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 25 | 3 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 25 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-04 | 188 | 25 | 3 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 25 | 3 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.57e-04 | 189 | 25 | 3 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 191 | 25 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.62e-04 | 191 | 25 | 3 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-04 | 191 | 25 | 3 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 192 | 25 | 3 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.67e-04 | 193 | 25 | 3 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class (2021.01.30) | 1.67e-04 | 193 | 25 | 3 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.67e-04 | 193 | 25 | 3 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.67e-04 | 193 | 25 | 3 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 1.67e-04 | 193 | 25 | 3 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 193 | 25 | 3 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.67e-04 | 193 | 25 | 3 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.67e-04 | 193 | 25 | 3 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.67e-04 | 193 | 25 | 3 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 194 | 25 | 3 | 3ef9e88e66f2f2ae95dcc834ea605c40c60783fc | |
| ToppCell | Control-Myeloid-Migratory_DC|Control / Condition, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | 374076e60dcee83eb1814aa6b55b77668909f40b | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 194 | 25 | 3 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 194 | 25 | 3 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-04 | 194 | 25 | 3 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 194 | 25 | 3 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 194 | 25 | 3 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 195 | 25 | 3 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 1.72e-04 | 195 | 25 | 3 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.78e-06 | 190 | 25 | 5 | 6718_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.18e-06 | 198 | 25 | 5 | 3876_DN | |
| Drug | gadodiamide | 1.96e-05 | 48 | 25 | 3 | ctd:C064925 | |
| Drug | hydroxyephedrine | 5.18e-05 | 10 | 25 | 2 | CID000009701 | |
| Drug | 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one | 5.18e-05 | 10 | 25 | 2 | ctd:C451219 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.18e-05 | 190 | 25 | 4 | 1483_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 5.40e-05 | 192 | 25 | 4 | 4449_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 2621_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 1219_DN | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 3124_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 4433_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 3848_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 1541_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 3676_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5436_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 3678_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 1241_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 6182_UP | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 6.32e-05 | 200 | 25 | 4 | 6415_DN | |
| Drug | PA-e | 6.36e-05 | 71 | 25 | 3 | CID000007994 | |
| Drug | AC1L9L1A | 1.04e-04 | 14 | 25 | 2 | CID000447615 | |
| Drug | sodium ampicillin | 1.38e-04 | 92 | 25 | 3 | CID000002173 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 6.03e-06 | 42 | 25 | 3 | DOID:8991 (is_marker_for) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.77e-05 | 11 | 25 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 7.29e-05 | 96 | 25 | 3 | C1319315 | |
| Disease | colorectal cancer (is_implicated_in) | 1.45e-04 | 121 | 25 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | mood instability measurement | 1.71e-04 | 128 | 25 | 3 | EFO_0008475 | |
| Disease | smoking behavior | 1.83e-04 | 341 | 25 | 4 | EFO_0004318 | |
| Disease | DNA methylation | 1.96e-04 | 656 | 25 | 5 | GO_0006306 | |
| Disease | azoospermia (implicated_via_orthology) | 2.39e-04 | 27 | 25 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 2.76e-04 | 29 | 25 | 2 | OBA_2045183 | |
| Disease | posterior urethral valve | 2.76e-04 | 29 | 25 | 2 | MONDO_0019640 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 2.95e-04 | 30 | 25 | 2 | OBA_2045180 | |
| Disease | level of Sphingomyelin (d40:1) in blood serum | 3.37e-04 | 32 | 25 | 2 | OBA_2045182 | |
| Disease | insomnia measurement | 4.94e-04 | 443 | 25 | 4 | EFO_0007876 | |
| Disease | post-traumatic stress disorder | 6.51e-04 | 202 | 25 | 3 | EFO_0001358 | |
| Disease | vascular endothelial growth factor measurement | 1.03e-03 | 56 | 25 | 2 | EFO_0004762 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.22e-03 | 61 | 25 | 2 | DOID:3587 (is_marker_for) | |
| Disease | hypertension, white matter hyperintensity measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0000537, EFO_0005665 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.52e-03 | 68 | 25 | 2 | EFO_0007826, EFO_0007860 | |
| Disease | pulse pressure measurement, alcohol drinking | 1.61e-03 | 70 | 25 | 2 | EFO_0004329, EFO_0005763 | |
| Disease | lung cancer (is_implicated_in) | 1.79e-03 | 74 | 25 | 2 | DOID:1324 (is_implicated_in) | |
| Disease | neuroimaging measurement | 1.79e-03 | 1069 | 25 | 5 | EFO_0004346 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.05e-03 | 301 | 25 | 3 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGMHHEAQQQAGESA | 1116 | Q5SNV9 | |
| GSEPNNDDKMNGHIH | 276 | Q96G01 | |
| GHELGHNLGMQHDTQ | 341 | O43506 | |
| MGHNLGMDHDENVQG | 336 | P78325 | |
| EDHNENGHTPLMEAG | 361 | O75179 | |
| HESGHNFGMIHDGEG | 436 | Q8TE60 | |
| HDPTQGMRQGNDHGT | 141 | Q9UJ68 | |
| HPDKMANDQGRHGDG | 1046 | P43146 | |
| GGTPLHDAAENGQME | 271 | Q6ZVH7 | |
| DHDHNDGGLLDPGFM | 4501 | Q9NZR2 | |
| LPQMMEGNGNGHEHC | 16 | P30419 | |
| EGNHFGNPQPSMDGE | 921 | Q9HBX8 | |
| NEGHFNNGSHMTDIP | 1201 | Q9HC56 | |
| PTNFNHVAHMGPGDG | 1586 | Q9Y5S2 | |
| GMLNNHGHAVPANGE | 451 | O15350 | |
| AHELGHNLGMNHDDG | 346 | Q13443 | |
| PEMLHGDGDNEEHGF | 781 | Q9ULF5 | |
| MFDPEQHPNHLGAGG | 696 | Q92523 | |
| SPEGHASDMEGQGHV | 516 | Q96RQ9 | |
| GEMQDHQEHPGLGSN | 601 | A7E2F4 | |
| NFNHIAHMGPGDGIQ | 1576 | Q5VT25 | |
| HVTMEHVGGPEQNNH | 281 | O60481 | |
| ENVQMNGDTPHDGGH | 411 | Q9Y6R1 | |
| AAPMAEGGGQNHHEV | 26 | P15692 | |
| THGEMPHGGQADDEV | 1001 | Q13308 |